Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Gastroesophageal Reflux 1

Interventions

Radiosurgery 28Magnetic Resonance Spectroscopy 25Blood Specimen Collection 20Radiotherapy 19Surveys and Questionnaires 18Exercise 16Early Intervention, Educational 16Methods 15Cyclophosphamide 15Surgical Procedures, Operative 14Standard of Care 14Radiotherapy, Intensity-Modulated 14Biopsy 13Acupuncture Therapy 12Interviews as Topic 11Cisplatin 11Filgrastim 10Educational Status 10Radiofrequency Ablation 9Magnetic Resonance Imaging 9Fluorodeoxyglucose F18 9fludarabine phosphate 8Radiation 8Gemcitabine 8X-Rays 7Sorafenib 7Practice Guidelines as Topic 7Granulocyte Colony-Stimulating Factor 7Colonoscopy 7Capecitabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Terminated × Esomeprazole × Clear all
NCT00222079 2017-12-14

Evaluation of Esomeprazole in Treating Gastro-esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy

University of Iowa

Phase NA Terminated
40 enrolled
Gastrointestinal

Gastroesophageal Reflux

Data powered by HemOnc (CC BY 4.0) Colophon âš¡